Merus NV Hits Day High with 36.67% Surge in Intraday Performance

Merus NV, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant activity today, with the stock surging 36.67% as of September 30, 2025. The stock reached an intraday high of USD 94.29, marking a notable milestone in its trading performance.
In terms of performance metrics, Merus NV has shown impressive gains over various time frames. Over the past year, the stock has increased by 97.21%, significantly outperforming the S&P 500, which rose by 16.09% during the same period. Year-to-date, Merus NV has achieved a remarkable 123.9% increase, while its three-year performance stands at an impressive 375.51%. Over the last five years, the stock has delivered a staggering 677.46% return.

Despite these gains, the company faces challenges, including a decline in net sales and negative operating cash flow. The stock's performance is juxtaposed with a negative EBITDA and a low debtors turnover ratio, indicating potential financial risks. As Merus NV continues to navigate these dynamics, its recent price movement highlights the volatility and complexity of the biotechnology market.